81.08
+0.02
+(0.02%)
At close: January 10 at 4:00:01 PM EST
81.08
0.00
(0.00%)
After hours: January 10 at 4:20:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-470,036.00
-296,790.00
-170,597.00
-121,393.00
-46,628.00
Investing Cash Flow
-1,462,424.00
-773,311.00
74,585.00
-212,308.00
-1,105.00
Financing Cash Flow
2,446,336.00
639,813.00
861,547.00
17,796.00
374,870.00
End Cash Position
1,060,113.00
398,554.00
835,528.00
69,856.00
386,200.00
Interest Paid Supplemental Data
--
--
2.00
7.00
7.00
Capital Expenditure
-146,201.00
-67,877.00
-5,848.00
-6,555.00
-1,155.00
Issuance of Capital Stock
2,435,625.00
636,043.00
856,480.00
13,896.00
373,886.00
Repayment of Debt
--
--
--
--
-61.00
Free Cash Flow
-616,237.00
-364,667.00
-176,445.00
-127,948.00
-47,783.00
12/31/2020 - 6/12/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ACLX Arcellx, Inc.
69.08
-4.40%
RVMD Revolution Medicines, Inc.
41.78
-5.94%
CNTA Centessa Pharmaceuticals plc
15.64
-2.86%
NUVL Nuvalent, Inc.
76.61
-2.10%
ASND Ascendis Pharma A/S
129.19
-3.90%
INSM Insmed Incorporated
65.25
-0.72%
STOK Stoke Therapeutics, Inc.
9.00
+0.45%
RYTM Rhythm Pharmaceuticals, Inc.
56.17
-2.94%
DYN Dyne Therapeutics, Inc.
15.87
-31.15%
CRNX Crinetics Pharmaceuticals, Inc.
40.59
-16.31%